@prefix adms: <http://www.w3.org/ns/adms#> .
@prefix dcat: <http://www.w3.org/ns/dcat#> .
@prefix dcatap: <http://data.europa.eu/r5r/> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix foaf: <http://xmlns.com/foaf/0.1/> .
@prefix healthdcatap: <http://healthdataportal.eu/ns/health#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix vcard: <http://www.w3.org/2006/vcard/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://catalogue.hdsu.nl/catalogue-rdf/api/rdf/Resources/id=ALL10> a dcat:Dataset ;
    dcatap:applicableLegislation <http://data.europa.eu/eli/reg/2022/868/oj> ;
    healthdcatap:numberOfUniqueIndividuals "778"^^xsd:nonNegativeInteger ;
    dct:accessRights <http://publications.europa.eu/resource/authority/access-right/NON_PUBLIC> ;
    dct:accrualPeriodicity <http://publications.europa.eu/resource/authority/frequency/NEVER> ;
    dct:creator <http://catalogue.hdsu.nl/catalogue-rdf/api/rdf/Agents/id=pmc&resource=ALL10> ;
    dct:description """The aim of Protocol ALL-10 is to improve the overall treatment results in terms of EFS and to decrease
treatment intensity in patients with a pEFS of >95%. Therapy will be tailored according to the risk of
relapse as determined by the MRD levels at 2 time points during the first months of therapy. This
tailored therapy should lead to less intensive therapy for patients with low risk of relapse and to
intensification of therapy for patients with medium and high risk of relapse."""@en,
        ""@nl ;
    dct:identifier <https://doi.org/10.71739/jr71-6h42> ;
    dct:issued "2026-03-06T10:34:35.370675"^^xsd:dateTime ;
    dct:modified "2026-04-13T21:30:27.954541"^^xsd:dateTime ;
    dct:provenance [ a dct:ProvenanceStatement ;
            rdfs:label """The aim of Protocol ALL-10 is to improve the overall treatment results in terms of EFS and to decrease
treatment intensity in patients with a pEFS of >95%. Therapy will be tailored according to the risk of
relapse as determined by the MRD levels at 2 time points during the first months of therapy. This
tailored therapy should lead to less intensive therapy for patients with low risk of relapse and to
intensification of therapy for patients with medium and high risk of relapse."""@en,
                ""@nl ] ;
    dct:publisher <http://catalogue.hdsu.nl/catalogue-rdf/api/rdf/Agents/id=pmc&resource=ALL10> ;
    dct:spatial <http://publications.europa.eu/resource/authority/country/NLD> ;
    dct:title "Protocol ALL 10, protocol voor diagnostiek en behandeling van kinderen en adolescenten (1-19 jaar) met Acute Lymfatische Leukemie (ALL)"@en,
        ""@nl ;
    adms:versionNotes ""@en,
        ""@nl ;
    dcat:contactPoint <http://catalogue.hdsu.nl/catalogue-rdf/api/rdf/Contacts/firstName=Hester&lastName=de%20Groot-Kruseman&resource=ALL10> ;
    dcat:keyword "Acute Lymfatische Leukemie"@en ;
    dcat:theme <http://publications.europa.eu/resource/authority/data-theme/HEAL> .

<http://catalogue.hdsu.nl/catalogue-rdf/api/rdf/Contacts/firstName=Hester&lastName=de%20Groot-Kruseman&resource=ALL10> a vcard:Kind ;
    vcard:fn "Hester de Groot-Kruseman" ;
    vcard:hasEmail <mailto:TDCSecretary@prinsesmaximacentrum.nl> .

<http://data.europa.eu/eli/reg/2022/868/oj> a <http://data.europa.eu/eli/ontology#LegalResource> .

<http://publications.europa.eu/resource/authority/access-right/NON_PUBLIC> a dct:RightsStatement .

<http://publications.europa.eu/resource/authority/country/NLD> a dct:Location .

<http://publications.europa.eu/resource/authority/frequency/NEVER> a dct:Frequency .

<http://catalogue.hdsu.nl/catalogue-rdf/api/rdf/Agents/id=pmc&resource=ALL10> a foaf:Agent ;
    dct:identifier <https://ror.org/02aj7yc53> ;
    vcard:hasEmail <mailto:info@prinsesmaximacentrum.nl> ;
    foaf:homepage <https://www.prinsesmaximacentrum.nl> ;
    foaf:name "Princess Máxima Center" .